よむ、つかう、まなぶ。
大腸がんファクトシート2024 (49 ページ)
出典
| 公開元URL | |
| 出典情報 | 大腸がん対策を推進するための「大腸がんファクトシート」公開（3／27）《国立がん研究センター》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
参考文献
第5章 大腸がんの治療
１） 大腸癌研究会. 大腸癌治療ガイドライン : 医師用: 金原出版, 2024.
１５） Okamura R, et al: Proposal of a stage-specific surveillance strategy for
２） Iwate M, Sano Y, Tanaka Set al: Validation study for development of the
colorectal cancer patients: A retrospective analysis of Japanese large
Japan NBI Expert Team classification of colorectal lesions. Dig Endosc
cohort. Eur J Surg Oncol 2018;44(4): 449-455
2018; 30(5): 642-651
１６） Ainhoa C, Govind N, Sarah T, et al: Treatment of Patients With Early-Stage
３） Kudo S, Hirota S, Nakajima T, et al. Colorectal tumours and pit pattern. J
colorectal Cancer: ASCO Resource-Stratified Guideline. J Glob Oncol
Clin Pathol 1994;47:880-885.
2019;5:1-19.
４） Matsuda T, et al：Efficacy of the invasive/ non-invasive pattern by
１７） Argiles G, Tabernero J, Labianca R:Localised colon cancer; ESMO Clinical
magnifying chromoendoscopy to estimate the depth of invasion of early
Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol
colorectal neoplasms. Am J Gastroenterol 2008;103(11):2700-2706.
2020;31(10):1291-1305.
５） Kudo S: Endoscopiv mucosal resection of flat and depressed early
１８） Simmonds PC: Palliative chemotherapy for advanced colorectal cancer:
colorectal cancer. Endosocopy 1993; 25(7): 455-461
systematic review and meta-analysis. Colorectal Cancer Collaborative
６） Tanaka S, Oka, Chayama K: Colorectal endoscopic submucosal
Group. BMJ 2000; 321(7260): 531-535
dissection (ESD): the present status and future perspective including its
１９） Yamada Y, Takahari D, Mastumoto H, et al: Leucovorin, fluorouracil, and
differentiation from endoscopic mucosal resection (EMR). J Gastroenterol
oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab
2008; 43(9): 641-651
in patients with metastatic colorectal cancer (SOFT): an open-label,
７） Tanaka S, Kashida H, Saito Y, et al: JGES guidelines for colorectal
non-inferiority, randomised phase 3 trial. Lancet Oncol 2013; 14(13):
endoscopic submucosal dissection/ endoscopic mucosal resection. Dig
1278-1286
Endosc 2015; 27(4): 417-434
２０） Loupakis F, Cremolini C, Masi G, et al: Initial therapy with FOLFOXIRI and
８） Ohata K, Kobayashi N, Sakai E, et al. Long-term Outcomes After
bevacizumab for metastatic colorectal cancer. N Engl J Med 2014; 371
Endoscopic Submucosal Dissection for Large Colorectal Epithelial
(17): 1609-1618
Neoplasms: A Prospective, Multicenter, Cohort Trial From Japan.
２１） Yamazaki K, Nagase M, Tamagawa H, et al: Randomized phase III study of
Gastroenterology 2022;163(5):1423-1434.e2.
bevacizumab plus FOLFIRI and bevacizumab plus mFOLFOX6 as first-line
９） 斎藤 豊、他: 大腸内視鏡スクリーニングとサーベイランスガイドライン. Gastroenterol
treatment for patients with metastatic colorectal cancer (WJOG4407G).
Endosc 2020; 62(8): 1519-1560
Ann Oncol 2016; 27(8): 1539-1546
１０） Saito Y, et al: Colonoscopy screening and surveillance guidelines. Dig
２2） Skibber JM, Hoff PM, Minsky BD, et al: Cancer of the rectum. In: Devita
Endosc 2021; 33: 486-519
VT, Hellman S, Rosenberg SA (eds) . Cancer: principles and practice of
１１） Oka S, Tanaka S, Kanao H, et al: Mid-term prognosis after endoscopic
oncology (6th ed). Philadelphia, Lippincott, Williams and Wilkins 2001;
resection for submucosal colorectal carcinoma: summary of a multicenter
questionnaire survey conducted by the colorectal endoscopic resection
standardization implementation working group in Japanese Society for
Cancer of the Colon and Rectum. Dig Endosc 2011; 23(2): 190-194
１２） 日本内視鏡外科学会学術委員会 著. 内視鏡外科手術に関するアンケート調査 : 第16回
集計結果報告, 日本内視鏡外科学会, 2022.11.
https://ndlsearch.ndl.go.jp/books/R100000002-I032498681
１３） Mastuyama T, Endo H, Yamamoto H, et al: Outcomes of robot-assisted
versus conventional laparoscopic low anterior resection in patients with
rectal cancer: propensity-matched analysis of the National Clinical
Database in Japan. BJS Open. 2022;5(5):202.
１４） Kobayashi H, et al: Characteristics of recurrence and surveillance tools
after curative resection for colorectal cancer: a multicenter study. Surgery
2007; 141(1):67-75
ー 48 ー
1271-1318
第5章 大腸がんの治療
１） 大腸癌研究会. 大腸癌治療ガイドライン : 医師用: 金原出版, 2024.
１５） Okamura R, et al: Proposal of a stage-specific surveillance strategy for
２） Iwate M, Sano Y, Tanaka Set al: Validation study for development of the
colorectal cancer patients: A retrospective analysis of Japanese large
Japan NBI Expert Team classification of colorectal lesions. Dig Endosc
cohort. Eur J Surg Oncol 2018;44(4): 449-455
2018; 30(5): 642-651
１６） Ainhoa C, Govind N, Sarah T, et al: Treatment of Patients With Early-Stage
３） Kudo S, Hirota S, Nakajima T, et al. Colorectal tumours and pit pattern. J
colorectal Cancer: ASCO Resource-Stratified Guideline. J Glob Oncol
Clin Pathol 1994;47:880-885.
2019;5:1-19.
４） Matsuda T, et al：Efficacy of the invasive/ non-invasive pattern by
１７） Argiles G, Tabernero J, Labianca R:Localised colon cancer; ESMO Clinical
magnifying chromoendoscopy to estimate the depth of invasion of early
Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol
colorectal neoplasms. Am J Gastroenterol 2008;103(11):2700-2706.
2020;31(10):1291-1305.
５） Kudo S: Endoscopiv mucosal resection of flat and depressed early
１８） Simmonds PC: Palliative chemotherapy for advanced colorectal cancer:
colorectal cancer. Endosocopy 1993; 25(7): 455-461
systematic review and meta-analysis. Colorectal Cancer Collaborative
６） Tanaka S, Oka, Chayama K: Colorectal endoscopic submucosal
Group. BMJ 2000; 321(7260): 531-535
dissection (ESD): the present status and future perspective including its
１９） Yamada Y, Takahari D, Mastumoto H, et al: Leucovorin, fluorouracil, and
differentiation from endoscopic mucosal resection (EMR). J Gastroenterol
oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab
2008; 43(9): 641-651
in patients with metastatic colorectal cancer (SOFT): an open-label,
７） Tanaka S, Kashida H, Saito Y, et al: JGES guidelines for colorectal
non-inferiority, randomised phase 3 trial. Lancet Oncol 2013; 14(13):
endoscopic submucosal dissection/ endoscopic mucosal resection. Dig
1278-1286
Endosc 2015; 27(4): 417-434
２０） Loupakis F, Cremolini C, Masi G, et al: Initial therapy with FOLFOXIRI and
８） Ohata K, Kobayashi N, Sakai E, et al. Long-term Outcomes After
bevacizumab for metastatic colorectal cancer. N Engl J Med 2014; 371
Endoscopic Submucosal Dissection for Large Colorectal Epithelial
(17): 1609-1618
Neoplasms: A Prospective, Multicenter, Cohort Trial From Japan.
２１） Yamazaki K, Nagase M, Tamagawa H, et al: Randomized phase III study of
Gastroenterology 2022;163(5):1423-1434.e2.
bevacizumab plus FOLFIRI and bevacizumab plus mFOLFOX6 as first-line
９） 斎藤 豊、他: 大腸内視鏡スクリーニングとサーベイランスガイドライン. Gastroenterol
treatment for patients with metastatic colorectal cancer (WJOG4407G).
Endosc 2020; 62(8): 1519-1560
Ann Oncol 2016; 27(8): 1539-1546
１０） Saito Y, et al: Colonoscopy screening and surveillance guidelines. Dig
２2） Skibber JM, Hoff PM, Minsky BD, et al: Cancer of the rectum. In: Devita
Endosc 2021; 33: 486-519
VT, Hellman S, Rosenberg SA (eds) . Cancer: principles and practice of
１１） Oka S, Tanaka S, Kanao H, et al: Mid-term prognosis after endoscopic
oncology (6th ed). Philadelphia, Lippincott, Williams and Wilkins 2001;
resection for submucosal colorectal carcinoma: summary of a multicenter
questionnaire survey conducted by the colorectal endoscopic resection
standardization implementation working group in Japanese Society for
Cancer of the Colon and Rectum. Dig Endosc 2011; 23(2): 190-194
１２） 日本内視鏡外科学会学術委員会 著. 内視鏡外科手術に関するアンケート調査 : 第16回
集計結果報告, 日本内視鏡外科学会, 2022.11.
https://ndlsearch.ndl.go.jp/books/R100000002-I032498681
１３） Mastuyama T, Endo H, Yamamoto H, et al: Outcomes of robot-assisted
versus conventional laparoscopic low anterior resection in patients with
rectal cancer: propensity-matched analysis of the National Clinical
Database in Japan. BJS Open. 2022;5(5):202.
１４） Kobayashi H, et al: Characteristics of recurrence and surveillance tools
after curative resection for colorectal cancer: a multicenter study. Surgery
2007; 141(1):67-75
ー 48 ー
1271-1318